To view the Enterprise Awards applications, please click on each award heading below.

Nomination Form »

The deadline for nominations is Friday, November 18th.

HEALTHCARE INNOVATOR

Sponsor: Independence Blue Cross

Criteria:

• The nominee can be a company, researcher, or investor providing an innovative solution that has the potential to make a large and positive impact on cost, quality, and/or access in health care.
• Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

• The Nominee must demonstrate creativity and passion to re-thinking healthcare in the region and to driving exceptional health outcomes or dramatically lowering costs.
• The nominee should have a demonstrated business model for its solution and demonstrate the ability to generate rapid growth or adoption.
• The Nominee can be in any sector (technology, life sciences, investment, healthcare delivery., etc.), but must be serving the healthcare industry in Greater Philadelphia.

INVESTMENT DEAL

Sponsor: Baker Tilly

Criteria:

• Deal must have been fully executed between November 1, 2021, and October 31, 2022.
• Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
• Events that qualify for this category include: IPO, Capital Raise, Buy-side or Sell-side of a Merger & Acquisition Transaction.

Key Considerations:

• Realized returns for the investors and management.
• EBITDA margin and revenue growth.
• Strategic considerations of the deal (e.g. commercial strategy, innovation, and contribution to market development.
• Company performance prior to transaction.
• How the sale or purchase impacted the broader industry(s) of the buyer and/or seller.

LIFE SCIENCES & HEALTHCARE STARTUP

Sponsors: Blank Rome and Ben Franklin Technology Partners

Criteria:

• Company should have been founded, launched meaningful operations, or pivoted to current strategic focus at some point between January 1, 2019, and December 31, 2022.
• Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

• Product innovation including unmet market need and how that is uniquely addressed by your product/service.
• The management team and its ability and record of achieving success.
• Provide demonstration of success (e.g., significant milestones, raising capital, revenue, etc.).
• Describe the R&D investment strategy.
• What did the company do to overcome challenges in financing, development, or commercialization?

LIFE SCIENCES & HEALTHCARE EMERGING

Sponsors: SAP and RSM

Criteria:

• Company must have been in operation beginning on January 1, 2019.  The Company should have no more than 8 years of operating results since its founding.
• Must have sales, grants, or licensing fees.
• Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

• Describe product or service, including proprietary applications or other competitive advantage.
• The impact on the clinical problem this product or innovation is trying to solve (e.g. saving a hospital money on a procedure, making a clinician more productive, etc.).
• Company milestones including strategic decisions made by the management team that led to growth in revenues and/or earnings, corporate collaborations, or license deals (e.g. ability to raise capital, strategy to achieve breakeven, ability to realize high gross margins, etc.).

LIFE SCIENCES & HEALTHCARE COMPANY OF THE YEAR

Criteria:

• Company must have at least four years of operating results in industry segments such as specialty pharmaceuticals, biotechnology, medical devices, instrumentation, therapeutics, diagnostics, health tech, etc.
• Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

• Company should demonstrate the impact of a proprietary product to the patient and/or clinician or research and development of an innovative product and its potential impact on the market.
• Company should demonstrate its ability to raise capital; achieve success in its development strategy and clinical pathway; commercialize and generate revenue.
• Describe any significant events, e.g. product discovery, drug registration, commercial launch, an exit, an increase in sales, etc. that occurred in 2022.
• What did the company do to overcome challenges in financing, development, or commercialization?

LIFE SCIENCES & HEALTHCARE CEO

Sponsors: EY and Morgan Lewis

Criteria:

• CEO must be in his/her position for at least two years.
• Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

• CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the Company.
• Leadership and impact in industry and/or market.
• Ability to attract and retain talented resources.
• Company milestones including financial accomplishments and a strategy for continued company success.
• Community/industry involvement.
• Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the life sciences/healthcare industry in the region.

TECHNOLOGY CEO

A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.

Sponsor: Cozen O’Connor

Criteria:

• Individual’s background (CV/Bio required) and the company’s success to date.
• The CEO must be in his/her position for at least two years.
• Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

• CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company.
• Leadership and impact in industry and/or market.
• Ability to attract and retain talented resources.
• Company milestones including financial accomplishments and a strategy for continued company success.
• Community and/or industry involvement.
• Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the technology industry in the region.

TECHNOLOGY COMPANY

A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.

Sponsor:  Comcast Business

Criteria:

• Company with more than $50 million in revenues projected for the current fiscal year.
• Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

• Leadership and product and/or service innovation in an industry or market.
• Significant company milestones including financial accomplishments.
• The Company’s connection and commitments to the Greater Philadelphia region through community and industry involvement.

TECHNOLOGY STARTUP

A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.

Sponsors: Troutman Pepper and Bank of America

Criteria:

• Company should have been founded, launched meaningful operations, or pivoted to current strategic focus at some point in the period between January 1, 2019, and December 31, 2022.
• Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

• Product or service innovation including market need or assessment.
• Potential for significant growth.
• The management team and its ability and record of achieving success.
• A demonstration of success such as significant milestones, raising capital, and revenue.

TECHNOLOGY EMERGING

A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.

Sponsors: Fox Rothschild and Broadpath

Criteria:

• Company must have been in operation before January 1, 2019.
• Revenues must be less than $50 million. *If revenues are projected to exceed $50m in 2022, please complete the Technology Company application.
• Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

• Product or service innovation, including proprietary technology or other advantage.
• Company milestones including strategic decisions made by management that led to growth in revenues and/or earnings.
• Strength of management team including ability to raise capital.
• Demonstration of a sustainable and scalable business model